An influential federal vaccine committee has voted to end the longstanding recommendation that all newborns receive the hepatitis B vaccine at birth. On March 15, 2024, the U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) made this decision with an 8-3 vote. The move has sparked widespread criticism from medical professionals across the United States, particularly in Maine.
The ACIP’s vote means parents of newborns born to mothers who test negative for hepatitis B are now advised to consult with their healthcare providers to determine if and when their child should be vaccinated. Critics argue that this change could jeopardize the health of infants and hinder access to vaccinations. Although the decision does not prevent parents from choosing to vaccinate their children at birth, experts fear that the absence of a strong recommendation will lead to a decline in the number of infants receiving the vaccine.
Dr. Laura Blaisdell, the immediate past president of the Maine chapter of the American Academy of Pediatrics, expressed her concerns in an interview, stating that “the science has not changed.” She emphasized that administering the hepatitis B vaccine shortly after birth is crucial in preventing the transmission of the virus from mother to child. “We are being subjected to a fringe agenda, to misinformation,” said Blaisdell, a pediatrician based in Portland.
The recommendation for administering the hepatitis B vaccine at birth has been in place since 1991. According to research from Johns Hopkins University, infections among vaccinated individuals have decreased by 99% since this guideline was established.
The Maine Center for Disease Control and Prevention has reiterated its support for the vaccine at birth. Spokesperson Lindsay Hammes stated, “The science supports timely vaccination as a vital public health measure, ensuring that all infants receive immediate protection, which is a critical safety net essential to protecting the health of our youngest and most vulnerable population.”
Dr. Cody Meissner, one of the dissenting voices on the panel, warned that thousands of children could face liver diseases if the new recommendations are adopted. “We are doing harm by changing this wording,” he cautioned.
While the ACIP’s recommendations are influential, the final decision rests with the CDC, which typically aligns with the advisory panel’s guidance. The panel’s vice chairman, Dr. Robert Malone, who voted to uphold the vaccination recommendation, highlighted the importance of parental choice. He stated, “There are these two fundamental differences of opinion about the rights of individuals versus the rights of society.”
The Maine Medical Association, alongside other health organizations, condemned the ACIP’s recent decision. Dr. Brian Youth, president of the Maine chapter of the American Academy of Pediatrics, emphasized the necessity of universal vaccination schedules. He noted that such schedules eliminate confusion, reduce missed doses, and ensure equitable care for all patients.
In addition to the vaccine recommendation, the ACIP also voted to require infants to receive a blood test after their first dose of the hepatitis B vaccine. Parents will be informed of the results to help them decide whether to continue with future doses. The hepatitis B vaccine involves a three-dose regimen that can provide lifelong protection against the disease. Dr. Blaisdell remarked on the potential issues with this new testing requirement, comparing it to not completing a course of antibiotics. She argued that not administering all three doses could leave infants vulnerable to the virus.
Caitlin Gilmet, a spokesperson for American Families for Vaccines, criticized the panel’s recommendation, calling it “unscientific” and indicative of a broader trend that places children at risk. Gilmet expressed concern that the federal panel has been compromised in its ability to make decisions that families have relied upon for decades.
As the debate continues, the implications of this decision for public health and the future of vaccination practices remain to be seen. The changes proposed by the ACIP have ignited discussions about the balance between individual rights and community health responsibilities in the context of childhood vaccinations.
